Objectives After completing this article, readers should be able to:
Introduction
Protein synthesis and accretion are the cornerstones of growth that provide the structural framework and enzymatic machinery necessary for fetal development. The maternal uterine circulation supplies the components that the fetus uses for protein accretion. All are derived from the maternal diet or maternal tissue stores. It is important to explore the regulatory processes within the maternal, placental, and fetal compartments that determine fetal amino acid retention. In addition to tissue synthesis, use of free amino acids as oxidative fuel is extensive in the well-nourished fetus and increases significantly during periods of maternal food deprivation. The changes in fetal amino acid utilization represent a significant mechanism by which the fetus adapts to energy deprivation.
Experimental Methodology
Before examining the available data, it is necessary to understand the models and methodology by which the data are derived. In general, four methods have been applied to fetal nitrogen metabolism: 1) carcass analysis, 2) net umbilical uptake determinations, 3) measurement of the rate of incorporation of a tracer amino acid into fetal protein, and 4) studies of the kinetics of amino acids in the fetal arterial free amino acid pool. Many studies have combined aspects of two or more of the these methods.
Carcass Analysis
For this method, individual fetuses are sacrificed at several points during gestation, and chemical analysis is performed on the carcass. The total amount of nitrogen, amino acid, or protein at that point in gestation can be determined. Data from individual fetuses are pooled to obtain an accretion curve. This method is analogous to construction of human intrauterine growth curves based on infants' weights born at various gestations.
Carcass analysis and calculation of specific growth rates can provide information that is not obtainable by alternative techniques. Each animal represents a single point on the resulting growth curve. The underlying assumption that the dynamic growth curve of a single fetus can be evaluated by static measurements made on multiple fetuses seems reasonable but cannot be tested. Biologic variability and inaccurate estimation of gestational age introduce error into these studies.
Net Arteriovenous Balance Determination
This methodology relies on the ability to determine umbilical blood flow and amino acid concentration accurately. It has been practical primarily in large ruminant animals. By the Fick principle, net uptake is equal to the umbilical blood flow multiplied by the whole blood arteriovenous concentration difference for the amino acid. The error inherent in the determination is equal to the error in the blood flow determination multiplied by the error in the amino acid concentration difference. Precise technology should result in an overall inherent error of less than 10%. If the inherent methodologic error is similar for each amino acid and total amino acid uptake is determined by summation, the potential error rate becomes large. A related problem is the difficulty in detecting real arteriovenous differences for amino acids that have an extraction coefficient near the inherent measurement error.
Measurement of the Rate of Incorporation of Tracer Amino Acid into Fetal Protein
Protein synthesis proceeds at a greater rate than net protein accretion and is counterbalanced by continuing protein breakdown. These processes occur even in a nongrowing animal and allow for the continuing remodeling of body protein. Body protein stores contract when breakdown exceeds synthesis; conversely, growth occurs when synthesis exceeds breakdown. Each process may be independently regulated, prompting studies of the control of protein kinetics.
Protein synthesis can be determined by introducing a labeled amino acid into the synthesis precursor pool and measuring its incorporation into protein. Use of this model requires determination of the amount of labeled amino acid in the pool that provides precursors for protein synthesis. Generally, this precursor is considered the specific activity of the free intracellular tracer amino acid. Although the transfer RNA (tRNA) tracer concentration is more correctly the immediate precursor to protein synthesis, analyzing for specific activity of this pool is difficult. There is evidence that the precursor pool-to-tRNA ratio may differ from one tissue to another or may exhibit a diurnal variability even within the same tissue. Most studies use the specific activity of either the plasma or the free intracellular pool. These experiments provide the fractional synthetic rate (K s ) of protein, which is the fraction of the protein pool that is synthesized per unit time. K s can be determined for the entire carcass or for specific tissues.
Kinetics of Amino Acids in the Fetal Arterial Free Amino Acid Pool
Plasma amino acid turnover refers to the flow of an amino acid into the plasma. Essential amino acids enter the free pool only from exogenous sources (eg, transplacental uptake in the case of the fetus) and from protein breakdown. Upon entering the free plasma amino acid pool, the entering substrate molecule dilutes the tracer substrate. The rate of appearance of the amino acid is estimated from this dilution. The rate of appearance is equal to the sum of protein breakdown and exogenous uptake. In addition, if the substrate is a nonessential amino acid, any endogenous synthesis is part of its rate of appearance. The rate of disappearance is equal to the rate of protein synthesis plus the rate of irreversible loss of the amino acid through oxidation. At steady state, the rate of appearance is equal to the rate of disappearance (ie, the sum of protein synthesis and oxidation).
Flux rates determined by this methodology represent integrated summations of the rates of protein synthesis and breakdown from each tissue within the organism. Factors that determine the influence of any individual tissue on the overall flux rate include the rate at which protein is synthesized in the tissue, the percent of total body mass accounted for by that tissue, and the relative percentage of the amino acid within the protein of the tissue. A tissue that has a fast turnover rate may influence flux rates out of proportion to its mass. A protein that has a slow rate of turnover but a large mass may greatly influence total body flux. The latter is the case with skeletal muscle, which turns over slowly relative to hepatic or gastrointestinal proteins, but still greatly influences total body amino acid flux because of its greater mass. Determination of amino acid flux rates measures the rate of tracer label dilution in the plasma amino acid pool.
Fetal Nitrogen Accretion
Carcass analysis data throughout gestation are available for several species, providing daily rates of accretion, increments of total nitrogen, and increments of individual amino acids. Despite a widely ranging rate of fetal growth, the total growth rate/nitrogen retention rate ratio is similar across species, with the rate of nitrogen retention slightly greater than that of total growth. This finding implies that the fetus becomes progressively enriched with nitrogen throughout gestation (Table) .
It should be noted that the fractional growth rate for most species is not constant throughout gestation. In most species, there is a gradual deceleration of growth rate that is most pronounced during the later stages of pregnancy.
In the human, cross-sectional studies have shown a marked deceleration in the growth rate after 36 weeks' gestation, and in some studies there is a suggestion of negative growth postterm. Sophisticated imaging techniques that allow longitudinal study of an individual fetus have raised doubts about whether such slowing of growth is usual. The human fetal fractional growth rate appears to be relatively stable at 1.5% per day from 24 to 34 weeks' gestation.
In the fetal lamb, amino acid nitrogen accounts for 82% of total carcass nitrogen. The concentrations of most amino acids decrease slightly over the second half of gestation. Only arginine, glycine, cysteine/cystine, and hydroxyproline evidence increased concentrations.
Fractional synthetic rates of protein are inversely proportional to gestation. Fractional rates of protein or nitrogen accretion are inversely proportional to gestational age, but the slope is less than for the relation between protein synthesis and gestational age. Early in gestation, there is a large difference between the two that progressively narrows as gestation proceeds. The precise mechanism of this finding is unclear. Possible explanations include an increase in the slow-turnover proteins, which constitute the carcass late in gestation, or a decreased requirement for protein remodeling as gestation progresses. Whatever the mechanism, it is clear that alterations in either the fractional synthetic rate or fractional breakdown rate may be important in the regulation of protein accretion.
Umbilical uptake studies have been reliably performed primarily in the fetal lamb model. These studies uniformly demonstrate that amino acid concentrations are higher in fetal than maternal blood, with the exception of glutamine. The initial studies of Lemons and associates demonstrated that the net uptake of amino acid carbon and nitrogen is significantly greater than would be required based on carcass analysis (Fig. 1) . The net balance varies for each amino acid. The neutral amino acids are taken up at a rate double their requirement for carcass accretion. The uptake of acidic and basic amino acids is nearly equal to the carcass accretion requirement, but net uptake of glutamate is negative, implying active fetal glutamate synthesis to supply fetal protein synthetic needs. It is possible that the net balance of several other amino acids is less than carcass accretion requirements.
Determinations of differences in umbilical arteryumbilical vein (UA-UV) concentrations of amino acids in the rat, measured acutely under anesthesia, are qualitatively similar to those seen in chronically studied sheep, although the actual concentrations are significantly greater. It is not possible to determine net umbilical uptake of amino acids in the human accurately, but simultaneous determinations of plasma aminograms from the UA and UV in the human have demonstrated differences similar to those seen in sheep at term and at mid-gestation. It is interesting that the magnitude of the UA-UV concentration difference is greater in the preterm human neonate than in the term human neonate. This occurs not only for those that have a positive umbilical balance (UV Ͼ UA), but for amino acids that have a negative umbilical balance (eg, glutamate). Without blood flow data, it is not possible to infer directly that umbilical uptake of amino acids decreased as gestation progressed. However, this observation is consistent with data in fetal sheep that demonstrate decreased fractional synthetic rates during late gestation.
Uterine uptake of many amino acids nearly matches simultaneously determined umbilical uptake, implying that the amino acid passes through the placenta unaltered, at least in net quantity (Fig. 2) . Notable exceptions include glutamine/glutamate, serine, and the branchedchain amino acids valine and leucine. For the branchedchain amino acids, enzymes in the placenta cause significant deamination. Similarly, cycling of amino acids between the placenta and the fetal liver have been described for glutamine/glutamate and serine/glycine. The guinea pig placenta has been shown to exhibit active amino acid transport sites on the maternal and fetal sides of the trophoblast. Net transport of amino acids from the mother to the fetus results from different transport rates at the two sites. Contrary to this implication is the evidence that the placenta is rich in amino acid transaminases, especially branched-chain amino acid transaminase, and evidence that free ammonia is produced within the placenta. It has been demonstrated that the uterine uptake of branched-chain amino acids is greater than simultaneous umbilical uptake. Available data suggest that a portion of the glutamate taken from the fetus by the placenta may be converted to glutamine and rereleased into the fetus. The purpose of such metabolic interconversions by the placenta remains to be elucidated, as does the use of the amino acid carbon skeleton as an oxidative fuel by the placenta.
Net uterine, but not umbilical, UA-UV differences of amino acids have been determined in several small species, in particular the guinea pig. These differences are consistent with little uptake of acidic amino acids and substantial uptake of several of the neutral amino acids. A study of the balance of fetal nitrogen must include ammonia. As stated previously, ammonia is produced within the placenta, presumably as the result of transamination of amino acids within trophoblastic tissue. It has not been shown conclusively that alpha-amino nitrogen is the source of this ammonia. In exercising skeletal muscle, which produces significant amounts of ammonia, the major source appears to be degradation of nucleotides, particularly adenosine. Because the placenta is metabolically an active organ, with a high rate of oxygen consumption, it is possible that adenosine triphosphate (ATP) degradation could be a significant source of placental ammonia production. Alternatively, the high activities of numerous transaminases make amino acids likely candidates. The ammonia produced within the placenta effluxes bidirectionally into the maternal and fetal circulations. This efflux may account for as much as 14% of total uteroplacental alpha-amino nitrogen uptake in the pregnant ewe. Absolute uterine ammonia production is relatively constant during the second half of gestation at approximately 500 mg/d nitrogen. When expressed as a fraction of the total uteroplacental nitrogen requirement, it is inversely proportional to gestational age. At 70 days' gestation, ammonia production may account for 44% of total nitrogen requirements, but by term it accounts for only 12%.
The fetus excretes waste nitrogen through urea synthesized in the fetal liver; fetal urea is disposed of across the placenta. On a weight-specific basis, ovine fetal urea synthetic rates are high, averaging 365 mg/kg per day in the fetus of a well-fed ewe. Humans have a significant urea concentration gradient from maternal arterial blood to fetal arterial blood, indicating substantial fetal urea production. Urea production increases by 100% during fasting of the ewe, with the activities of the five urea cycle enzymes increasing simultaneously.
Protein Metabolism in Specific Fetal Tissues
Rates of protein synthesis and degradation have been determined in a number of fetal tissues. Using 14C-labeled tyrosine in the ovine fetus, Schaeffer and Krishnamurti have shown that fractional synthetic rates tend to be greater for gastrointestinal tissues, with a fractional synthetic rate of more than 75%. Gastrointestinal tissues contribute 20% of total fetal whole-body protein synthesis. Skeletal muscle contributes 20% of total fetal wholebody protein turnover despite a much smaller fractional synthetic rate of only 12%, reflecting the much larger muscle mass in the fetal body. Other fetal tissues, including the brain, liver, heart, lung, and kidney, have fractional synthetic rates similar to those of muscle, but because of their smaller masses, they contribute less to whole-body protein turnover.
In the rat, fetal whole-body fractional synthetic rates decline during the gestation from 73%/d on day 14 to 38%/d on day 20 (term gestation is 21 days). Likewise, the Ks of individual tissues declines. The Ks for the kidney declines from 94% on day 18 to 63% on day 20 and for the liver declines from 112% on day 16 to 98% on day 20. These rates, expressed per day, are much greater than those found in sheep. However, expressed as a fraction of gestational length, they are comparable.
A number of studies have been performed in fetal sheep using tracer quantities of labeled amino acids. These studies have employed tyrosine, leucine, or lysine labeled with either 3H or 14C. The rates of protein synthesis and amino acid oxidation have been determined from these experiments. Absolute rates of protein synthesis are variable among studies, ranging from 63 to 38.6 to 15 g/kg per day. All studies have shown much higher rates of protein synthesis in the fetal lamb compartment than are seen simultaneously in the ewe. A more than 50% decrease in protein synthesis rates is seen in fetuses of ewes fasted for 48 hours. This study, which used tyrosine as the tracer, demonstrated a rate of irreversible tyrosine loss that was greater than the net utilization. Net placental uptake was negative, and the largest fraction of tyrosine rate of appearance was from endogenous fetal production. A relatively high rate of amino acid oxidation has been observed, as might be predicted from the high rates of fetal urea excretion that are known to occur. Fasting of the ewe has also been shown to increase the oxidation rate of both tyrosine and leucine.
Leucine balance and utilization have been extensively documented, and a net balance of leucine transport and utilization for the fed-state ovine fetus can be estimated. Uteroplacental uptake of leucine considerably exceeds umbilical uptake. Although it has not been shown that placental ammonia production arises from leucine alphaamino nitrogen, leucine nitrogen could account for nearly one third of placental ammonia production. The fate of the leucine carbon skeleton is not yet known. A portion is returned to the fetal and maternal circulation as the deamination product alpha-ketoisocaproate. It is possible that a portion is oxidized within the placenta.
Umbilical leucine uptake accounts for 25% of the total metabolism protein & amino acids leucine rate of appearance in fetal plasma. The rate of appearance of leucine is the sum of umbilical uptake plus the endogenous leucine produced by protein breakdown. Endogenous leucine appearance accounts for 75% of total leucine flux. Because leucine is an essential amino acid, the endogenous appearance can result only from protein breakdown. Leucine oxidation accounts for approximately 20% of total leucine flux; 50% of leucine uptake is oxidized. This finding is not unexpected because the rate of leucine accretion into the fetal carcass accounts for only 50% to 60% of leucine umbilical uptake.
By knowing the percentage of leucine in the average fetal protein, one can extrapolate the leucine data to ovine fetal protein turnover in general. It is likely that the other branched-chain amino acids, isoleucine and valine, behave similarly. Most other neutral amino acids, which are taken up in excess to their tissue accretion, are metabolized similarly. Using 490 mcmol leucine per gram of protein, the ovine fetal protein turnover rate is estimated to equal 40 g/d of protein, which compares to a protein accretion rate of 10 to 12 g/d for a 4,000-g fetus.
The data of Meier and colleagues obtained using lysine as a tracer suggested similar estimates of protein turnover (32 to 53 g/d) for late-gestation ovine fetuses. In addition, in this study, determination of the Ks allowed a second estimate of protein synthesis. The two estimates were close, with the estimate that was determined by the fractional synthetic rate being somewhat greater. Schaeffer and Krishnamurti, using tyrosine as a tracer, have suggested higher estimates of ovine fetal protein turnover than are derived from the leucine and lysine methods. The reasons for this discrepancy are not clear.
Relation Between Protein Synthesis and Energy Consumption
Numerous investigators have noted a correlation between energy consumption and rates of protein synthesis determined from amino acid flux rates. The allometric equation is used to relate physiologic processes to the dimensions of the organism. The metabolic rate in postnatal animals is generally proportional to body mass and is believed to be a consequence of the necessary equality between heat production and heat dissipation. Heat loss, which occurs at the body surface, must be proportional to body surface area, which should result in the metabolic rate being proportional to the two thirds power of mass.
During prenatal and postnatal life, protein synthetic rates scale to an exponent similar to that of energy consumption. Energy requirements for growth may be calculated in several ways. In postnatal life, subjects can be studied over long periods. Presumably they are growing at different rates, and a plot of energy intake versus weight gain can be constructed. The slope of this line is an estimate of the calories per gram weight gain needed for growth. In human neonates, it has led to an estimate of 0.7 kcal/g weight gain, which includes the total cost of growth, not simply protein synthesis.
In the fetus, estimates must be made from the known heat of formation of the peptide bonds that are needed to synthesize protein. These calculations lead to an estimate of 0.86 kcal (3.6 kJ) per gram of protein synthesized. If the protein synthetic rate for a hypothetical 3.5-kg fetus is 35 g/d, approximately 30 kcal (8.6 kcal/kg per day) are estimated to be devoted to protein synthesis. The oxygen consumption of the late-gestation 3-to 4-kg fetus is 6 to 7 mL/kg per minute, equivalent to an energy consumption of about 50 kcal/kg per day. Protein synthesis accounts for approximately 17% of the total fetal oxidative metabolism. This figure seems to be a reasonable approximation and is close to that estimated for protein synthesis in other species.
It should not be surprising that these two processes are correlated because each occurs primarily in the lean body mass. Whether there is any deeper significance to this relation remains to be determined. Although 17% of energy consumption is significant, much of it is obligatory replacement of protein that has broken down, which is necessary for survival.
Effects of Maternal Fasting
During fasting of the pregnant ewe, it appears that the fetus undergoes changes in metabolism that result in amino acids substituting as oxidative substrate for glucose. This change is necessary because the supply of glucose to the fetus falls by 50% in response to fastinginduced maternal hypoglycemia. During normoglycemia, glucose accounts for 50% to 75% of oxidative substrate, and amino acids account for 25%. Fasting causes amino acids to substitute for glucose, resulting in increased fetal urea production, which doubles by the fifth day of a prolonged fast. Umbilical uptake of amino acids does not appear to change quantitatively or qualitatively.
The ovine fetus responds to maternal fasting similarly to a postnatal nonruminant animal, although certain aspects are not yet clear. It can be surmised that alanine and glutamine carry nitrogen and possibly carbon from muscle protein stores to the fetal liver and kidney, but this has not been demonstrated in the fetus. It has not been demonstrated conclusively that gluconeogenesis from amino acid carbon can be accomplished by the metabolism protein & amino acids ovine fetus, although there is strong circumstantial evidence that it can occur, at least to a small extent. This evidence includes alanine carbon incorporation into glucose and the observation that nearly 25% of fetal lactate is derived from noncarbohydrate precursors. Gilfillan and associates demonstrated that alanine is produced by the late-term human fetus. Lemons and associates demonstrated that the enzymes responsible for gluconeogenesis are induced in the ovine fetus in response to maternal fasting. Taken together, these data are suggestive of gluconeogenesis in the ovine fetus during prolonged hypoglycemia. A large body of evidence from the rat fetus and neonate suggests that rodent fetuses are not capable of gluconeogenesis until enzyme induction, which takes place after parturition.
Finally, the origin of the excess amino acids for oxidative substrate during maternal fasting is not clear. It has been shown that net umbilical uptake of amino acids does not increase during fasting. One possibility is a diminished growth rate during fasting, freeing the nitrogen that would be used for tissue synthesis for oxidation without decreasing total body nitrogen. Alternatively, there may be a net catabolism of fetal tissue amino acid stores.
Hormonal Regulation of Fetal Protein Metabolism Insulin
Clinical evidence suggests that insulin is an important regulator of growth in the human fetus. Macrosomia accompanies the fetal hyperinsulinemic syndromes (eg, maternal diabetes, Beckwith-Wiedemann syndrome, nesidioblastosis). Conversely, growth retardation is found in the rare infant born with pancreatic aplasia. Chronic hyperinsulinemia in the fetal rhesus monkey induces macrosomia and cardiomegaly. Hyperinsulinemia has profound effects on fetal body composition in the human, with a large increase in the amount and percent of total body fat mass. Lean body mass is greatly increased, although as a percentage of body mass it may be decreased, reflecting a disproportionate increase in body fat mass.
Milley and colleagues demonstrated decreased arterial concentration and increased fetal uptake of alpha-amino nitrogen when the late-gestation ovine fetus was infused with exogenous insulin. The increased fetal amino acid uptake resulted in increased tissue synthesis, expansion of intracellular amino acid pools, and increased catabolism, but the partitioning between these fates remains to be determined. It is interesting to note that these investigators were not able to document increased birthweight in fetal lambs infused chronically with insulin. Other investigators have not been able to show any increase in body or protein mass in rat fetuses injected with insulin during late gestation. Fetal pigs fail to show any significant effect of insulin on growth. However, researchers have documented a 10% increase in total body nitrogen in rat fetuses following insulin injection and a significant 33% increase in body mass with chronic insulin infusion in the fetal rhesus monkey. Although chemical analysis of the carcasses was not performed, it can be presumed that the total body nitrogen was increased, but not likely to the same degree as body mass. The protein/DNA ratio was not changed, implying that any increase in lean body mass is primarily the result of tissue hyperplasia rather than hypertrophy.
Investigators have shown that fetal size is substantially less in a diabetic rat model than in controls. Fetal total protein content is decreased in concert with diminished body size. Fetal fractional synthetic rates are decreased in the rat fetuses of diabetic mothers, whereas fractional breakdown rates are markedly elevated. The placentas of these pups have diminished rates of protein breakdown but normal synthetic rates, the net result being placentomegaly in fetuses of diabetic mothers. These findings are intriguing because it is generally held that fetal tissue responds to hyperinsulinemia by hypertrophy or hyperplasia or both, but the placenta generally is believed not to be an insulin-sensitive organ. Further investigation is warranted to determine if these effects in the rat can be demonstrated in other species.
Little is known about the effect of insulin on fetal protein kinetics. Generally, increasing plasma insulin concentrations in postnatal animals causes movement of plasma amino acids into muscle cells, thereby decreasing arterial plasma concentrations. Insulin promotes protein deposition. It is controversial as to whether it occurs primarily because of increased protein synthesis or decreased protein breakdown. However, evidence from tracer kinetic modeling supports the latter as the major insulin effect. In adult human studies, kinetics of the branched-chain amino acids are affected by alterations in the glucose and insulin supply to a greater extent than are those of other amino acids.
Several recent studies have attempted to address the role of insulin's effect on in vivo amino acid kinetics. It has been difficult to differentiate the effects of insulin and glucose because the concentrations generally are highly correlated. In a series of three studies, Liechty and associates attempted to differentiate these effects. In the first two experiments, glucose was infused into fetal sheep, allowing insulin concentrations to rise in response or not metabolism protein & amino acids allowing such a rise by means of a somatostatin "insulin clamp." In the final study, hyperinsulinemia was induced by fetal insulin infusion, with glucose concentration held constant by the glucose clamp technique.
The consistent finding among all three experiments was no significant change in leucine rate of appearance despite large changes in insulin concentration. Additionally, no consistent changes were observed in leucine net umbilical uptake. Because the rate of appearance of an essential amino acid is considered reflective of appearance from protein breakdown, these studies have been interpreted as failing to demonstrate a role of insulin in suppressing fetal proteolysis.
Insulin also does not appear to have a direct role in stimulation of fetal protein synthesis. Rather, its effect appears to be mediated through increases in glucose utilization, thereby sparing leucine from oxidation. It is then more available for use for protein synthesis. The overall conclusion from these studies is that insulin has no effect on fetal proteolysis. However, through stimulation of fetal glucose utilization, insulin does have a role in the partitioning of glucose and amino acids to oxidation or tissue accretion, thus increasing protein synthesis.
Milley demonstrated a small decrease in leucine appearance from protein breakdown in spite of no statistically significant change in total plasma leucine. It is unclear whether the differences in the findings between these investigations are due to the model for analysis or differences in experimental protocols. However, it is clear that any effect insulin may have in decreasing fetal proteolysis is not of the magnitude seen in postnatal subjects, where suppression of proteolysis by 50% is commonly demonstrated.
Other indirect evidence regarding the effect of insulin on amino acid kinetics in the fetus comes from observations during fasting, when the fetal insulin concentration falls to an undetectable concentration. During maternal fasting, use of amino acids as oxidative substrate increases substantially, but total umbilical uptake does not change. This situation occurs despite maternal hypoaminoacidemia. Fetal amino acid concentrations in general remain constant or increase during maternal fasting or with other experimental conditions that lower maternal amino acid concentrations. Postnatally, the lambs' response to fasting is similar to that of the adult, with decreased amino acid concentration, a reduction in protein synthesis, and increased protein breakdown. Insulin infusion has no effect on leucine kinetics in fed lambs and causes a decrease in both protein synthesis and protein breakdown in fasted lambs.
Insulin-like Growth Factor-I (IGF-I)
Although studies of the IGF-I system in the ovine fetus are limited, several investigations in sheep and other mammalian species suggest that IGF-I may be involved in the regulation of fetal growth. Plasma concentrations of IGF-I have been shown to correlate directly with birthweight in humans and other species. In addition, lowered concentrations of IGF-I have been found in association with experimentally induced fetal growth retardation. Such observations have been made in rats and sheep in which fetal growth retardation has been induced by restricting maternal nutrient intake. Jones and colleagues found IGF-I concentrations to be reduced by 50% in a fetus carried by a ewe that had a previous carunculectomy that was associated with a 30% decrease in fetal body mass. It is also clear that the fetal IGF-I system responds to nutritional regulation. In the fasted fetal sheep model, provision of intravenous glucose supplementation to the ewe resulted in a rapid (ie, within 4 h) return of fetal IGF-I concentrations to normal.
Several studies have documented an effect of IGF-I on ovine fetal amino acid kinetics. In one, there was a 30% decrease in fetal urea production, reflective of a decrease in overall amino acid oxidation, when recombinant human IGF-I was infused into the fetus. Using a similar rhIGF-I infusion protocol, other investigators demonstrated a 10% to 15% decrease in leucine rate of appearance and a lesser decrease in leucine oxidation. These data support a role of IGF-I in the fetus to decrease protein breakdown and catabolism, with a net effect of increased tissue accretion. These conclusions are supported by results from an experiment in which IGF-I was infused into the fetus from 120 to 130 days of gestation. Infused fetuses had significantly greater liver, lung, kidney, and heart masses than did saline-infused controls.
Intrauterine Growth Retardation (IUGR)
Studies in human pregnancies complicated by IUGR and in animal models of IUGR have demonstrated alterations in amino acid metabolism. The effects on amino acid metabolism may be related primarily to a reduction of fetal amino acid availability due to a decrease in transplacental amino acid transport. Alternatively, changes in fetal amino acid utilization may represent an adaptive mechanism to permit survival of the fetus under lessthan-optimal conditions.
Human Studies
Fetal amino acid metabolism in IUGR has been examined in humans by measuring amino acid concentrations metabolism protein & amino acids in the umbilical artery or vein at the time of delivery using the doubly-clamped umbilical cord technique or by transabdominal umbilical cord sampling under ultrasonography guidance (ie, cordocentesis). These studies have demonstrated that at term small-for-gestational age (SGA) infants have decreased plasma concentrations of total alpha-amino nitrogen compared with normally grown appropriate-for-gestational age (AGA) infants. This decrease was demonstrated in both the umbilical artery and vein. Most of the difference was accounted for by a decrease in the branched-chain amino acids valine, leucine, and isoleucine. However, lower concentrations of other essential amino acids (eg, threonine, lysine, and histidine) and nonessential amino acids (eg, glutamine, glycine, serine, and taurine) were also observed in umbilical venous plasma. The greater differences in amino acid concentrations in the vein compared with the artery in SGA fetuses may reflect differences in the regulation of amino acid transport by the placenta or altered fetal utilization of amino acids for energy production and protein synthesis. Cetin and associates demonstrated that at term AGA fetuses had significantly positive venoarterial concentration differences for most of the essential amino acids as well as for total alpha-amino nitrogen. In contrast, SGA fetuses had significantly positive venoarterial concentration differences only for methionine, lysine, histidine, and arginine, but not for total alpha-amino nitrogen. This latter finding suggests a decrease in umbilical uptake of amino acids.
Economides and colleagues measured plasma concentrations of amino acids in umbilical venous blood samples obtained by cordocentesis in preterm AGA and SGA fetuses from 16 to 36 weeks' gestation. Although there was no difference in total alpha-amino nitrogen between AGA and SGA fetuses, SGA fetuses had lower concentrations of essential, basic, and branched-chain amino acids. In both preterm and term fetuses, there were positive correlations between maternal arterial and umbilical venous amino acid concentrations. Higher concentrations of amino acids were present in the fetal circulation, consistent with active placental amino acid transport.
Compared with AGA fetuses, SGA fetuses have lower fetomaternal ratios for most amino acids, but especially for essential and branched-chain amino acids. This latter finding is consistent with decreased transplacental amino acid transport in SGA fetuses. Of interest is the finding in preterm SGA fetuses of a significant correlation between the decrease in plasma concentration and fetomaternal ratio of the essential amino acids and the degree of fetal hypoxemia. This correlation indicates that hypoxemia may be an important cause of the decrease in amino acid uptake and utilization in IUGR.
Animal Studies
Animal models of IUGR have also demonstrated alterations in fetal amino acid metabolism. In rats, chronic maternal hyperinsulinemia produced by continuous subcutaneous infusion of insulin results in maternal hypoglycemia and lower total plasma amino acid concentration. The fetuses from these pregnancies are hypoglycemic, hypoinsulinemic, and growth-retarded. In addition, fetuses have lower concentrations of total plasma amino acids but no differences in specific amino acids. No difference was found in placental gas exchange in this model. In contrast, bilateral uterine artery ligation in rats resulted in fetal hypoglycemia, hypoinsulinemia, and IUGR as well as profound alterations in placental gas exchange with fetal hypoxia and hypercarbia. Similar to the findings in human studies, the SGA rat fetuses had reduced concentrations of valine, leucine, and isoleucine compared with control pups and significantly lower fetomaternal ratios of the branched-chain amino acids. These studies demonstrate that limited maternal fuel availability, specifically glucose and branched-chain amino acids, and fetal hypoxia, hypercarbia, and acidosis are contributing factors in IUGR.
Mechanisms
The specific alterations in fetal and placental amino acid metabolism in IUGR are areas of active investigation. Decreased fetal plasma amino acid concentrations may result from reduced umbilical uptake of amino acids, which in turn may be due to decreased placental perfusion, altered transplacental transport, or both. Alternatively, decreased amino acid concentrations may be due to increased fetoplacental amino acid utilization for energy production under conditions of limited glucose availability, as previously described for acute maternal starvation. Depending on the cause of the fetal growth retardation, any one or a combination of several of these factors may contribute to altered amino acid metabolism.
Amino acid kinetics have been studied in IUGR in the ovine fetus using stable and radioactive isotopes of leucine. Leucine is of particular interest in these models because it is extensively oxidized in the fetus under normal circumstances. In addition, as previously noted, most of the decrease in amino acid concentration observed in SGA fetuses is accounted for by a decrease in the branched-chain amino acids. Furthermore, the rate of leucine oxidation has been shown to increase in response to acute maternal starvation.
metabolism protein & amino acids
In the sheep, prolonged uterine blood flow reduction results in hypoxemia and restricted fetal growth, as demonstrated by a 20% reduction in daily weight gain and a 38% decrease in linear growth rate. Positive correlations were found between growth rate and arterial oxygen content, once again suggesting a role for oxygen in the regulation of fetal growth. In this model, as in the human SGA fetus, significant reductions were found in the whole blood concentrations of the branched-chain amino acids. Alanine, tyrosine, and phenylalanine concentrations were increased. The decrease in branchedchain amino acid concentration was associated with a decrease in the net umbilical uptake of isoleucine and leucine as well as the sum of the branched-chain amino acids. In addition, leucine turnover rate was reduced by 20% from 35 mcmol/min to 28 mcmol/min. In contrast to acute maternal starvation, fetal leucine oxidation decreased by 25% from 8 mcmol/min to 6 mcmol/min. The decrease in leucine turnover in this model of IUGR may provide a substantial savings in fetal energy expenditure in the face of reduced oxygen delivery.
In an examination of the effect of acute fetal hypoxia on amino acid uptake and protein metabolism, 3 hours of fetal hypoxia resulted in decreased umbilical uptake of glucose, lactate, and alpha-amino nitrogen such that endogenous rather than exogenous substrates were used to support fetal oxidative metabolism. Furthermore, alpha-amino nitrogen uptake was less than normal nitrogen accretion rates, suggesting that fetal growth must be compromised as a result of hypoxia. In a similar experiment, other investigators demonstrated that fetal protein synthetic rate declined by 60% during acute hypoxia. It is unclear if similar decreases in protein breakdown occurred, but to sustain fetal growth at normal rates, protein breakdown would have to be negligible, a condition that is unlikely. In addition, 3 hours of hypoxia resulted in a significant decrease in fetal oxygen consumption. The decrease in protein synthetic rate accounted for 70% of the decrease in oxygen consumption during fetal hypoxia. It is unclear whether this diminution in protein synthesis is simply a consequence of the decreased tissue PO 2 or hormonal regulation, but it appears that by decreasing protein synthetic rates, the fetus can diminish its oxygen requirements, albeit at the expense of diminished growth.
Ross and associates have further examined amino acid kinetics in IUGR in fetal sheep. Pregnant sheep were exposed to chronic heat stress beginning early in gestation, a model that has been shown to result in fetal growth retardation and hypoglycemia with impaired transplacental glucose transport. Fetal arterial plasma leucine concentration was reduced, and net uterine and uteroplacental uptake were significantly less in IUGR fetuses compared with controls. Net umbilical uptake was also lower in IUGR fetuses, but this difference did not persist when normalized to fetal weight. As with prolonged uterine blood flow reduction, heat-stressed IUGR fetuses had a 28% decrease in fetal plasma leucine turnover rate. Leucine flux from placenta to fetus was nearly 30% lower in IUGR fetuses, primarily as a result of a decrease in the direct flux of leucine from the maternal to fetal circulation. The decrease in maternal leucine transfer was balanced by a 50% reduction in the back-flux of leucine from the fetus to the placenta. Both fetal leucine oxidation and fetal leucine back-flux into the placenta were correlated with leucine concentration. From these data, it appears that the decreased plasma leucine concentration in IUGR fetuses results from the decrease in leucine flux from the maternal to fetal circulation. The lower fetal plasma concentration in turn determines the back-flux of leucine from the fetus to placenta as well as fetal leucine oxidation.
Amino Acid Transporters
In the heat-stressed model of IUGR, net flux of leucine into the uterus and the direct flux of leucine from the maternal to fetal circulation were significantly lower as a function of both fetal and placental weight. These findings are highly suggestive of a reduction in transplacental amino acid transporter activity. The suspicion that a defect in amino acid transport is an important factor in IUGR is supported by the observation that in both human and animal models of IUGR, the branched-chain amino acids, which share the L-transport system, appear to be affected similarly. Further support for a primary impairment of amino acid transporter activity in IUGR comes from studies in animal models as well as studies of microvillous membrane vesicles from SGA human pregnancies using artificial analogues of amino acids. In guinea pigs, growth retardation induced by unilateral uterine artery ligation was associated with a significant reduction in the placental transfer of aminoisobutyric acid (AIB), a nonmetabolizable amino acid transported by the system A Naϩ-dependent transporter. Similar findings of a defect in the system A transporter have been identified in microvillous membrane vesicles from the placentas of SGA infants using AIB. The decrease in AIB uptake by vesicles from placentas of SGA babies was due to a significantly lower V max but not in K m compared with vesicles from placentas of AGA babies.
A reduction in amino acid transport, therefore, would metabolism protein & amino acids
